Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “United Kingdom”
Sponsor: EyeBiotech Ltd.
Macular Degeneration · Age-Related Macular Degeneration · Choroidal Neovascularization · Wet Macular Degeneration
United States, Argentina, Australia, Israel, Latvia +3 more
Sponsor: AbbVie
Hidradenitis Suppurativa
United States, Argentina, Australia, Austria, Belgium +32 more
Sponsor: Merck Sharp & Dohme LLC
Leukemia, Lymphocytic, Chronic, B-Cell · Leukemia, Chronic Lymphocytic · Small-Cell Lymphoma · Lymphoma, Small Lymphocytic
United States, Argentina, Australia, Belgium, Brazil +13 more
- An Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of BMN 351 in Participants With Duchenne Muscular DystrophyEnrolling By Invitation
Sponsor: BioMarin Pharmaceutical
Duchenne Muscular Dystrophy (DMD)
Italy, Netherlands, Spain, Turkey (Türkiye), United Kingdom
Sponsor: Neurocrine Biosciences
Major Depressive Disorder
United States, Belgium, Bulgaria, Canada, Croatia +15 more
Sponsor: UCB Biopharma SRL
Alzheimer's Disease
United States, Belgium, Canada, France, Germany +5 more
Sponsor: Merck Sharp & Dohme LLC
Hematologic Malignancies · Waldenstroms Macroglobulinaemia · Non-Hodgkins Lymphoma · Chronic Lymphocytic Leukaemia
United States, Argentina, Australia, Brazil, Canada +17 more
Sponsor: Debiopharm International SA
Acromegaly
United States, Austria, Belgium, Brazil, Bulgaria +16 more
- Apremilast Pediatric Study in Children With Active Oral Ulcers Associated With Behçet's DiseaseRecruiting
Sponsor: Amgen
Behçet Disease
France, Greece, Israel, Italy, Spain +3 more
- A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic AnemiaActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Warm Autoimmune Hemolytic Anemia (wAIHA)
United States, Argentina, Australia, China, France +11 more
Sponsor: Amgen
Atopic Dermatitis
United States, Argentina, Australia, Brazil, Canada +4 more
- A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late XerostomiaActive Not Recruiting
Sponsor: MeiraGTx, LLC
Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands
United States, Canada, United Kingdom
- Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPCRecruiting
Sponsor: Novartis Pharmaceuticals
Prostate Cancer
United States, Australia, Brazil, China, Hong Kong +6 more
Sponsor: Amgen
Atherosclerotic Cardiovascular Disease · Overweight · Obesity
United States, Argentina, Australia, Austria, Belgium +31 more
- Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2)Active Not Recruiting
Sponsor: Novartis Pharmaceuticals
Systemic Lupus Erythematosus
United States, Argentina, Australia, Chile, Colombia +10 more
- Avacostar - (PASS)Active Not Recruiting
Sponsor: Vifor Fresenius Medical Care Renal Pharma
ANCA-associated Vasculitis
Germany, United Kingdom
- A Study of Acalabrutinib vs Investigator's Choice of Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in R/R CLLActive Not Recruiting
Sponsor: Acerta Pharma BV
Chronic Lymphocytic Leukemia
United States, Australia, Austria, Belgium, Bulgaria +20 more
Sponsor: Biotest
Community-acquired Pneumonia
United States, Argentina, Australia, Austria, Belgium +13 more
Sponsor: Crinetics Pharmaceuticals Inc.
Congenital Adrenal Hyperplasia · Classic Congenital Adrenal Hyperplasia
United States, Argentina, Australia, Belgium, Brazil +6 more
- Ascending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer AgentsActive Not Recruiting
Sponsor: AstraZeneca
Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer
United States, France, South Korea, United Kingdom
Sponsor: Boston Scientific Corporation
Cardiac Disease
Belgium, Canada, France, Germany, Greece +5 more
- A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)Active Not Recruiting
Sponsor: Hoffmann-La Roche
Multiple Sclerosis
United States, Argentina, Belgium, Brazil, Bulgaria +17 more
- DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine CancersNot Yet Recruiting
Sponsor: Boehringer Ingelheim
Small Cell Lung Cancer · Large Cell Neuroendocrine Lung Carcinoma · Extrapulmonary Neuroendocrine Carcinoma of Small Cell Histology · Extrapulmonary Neuroendocrine Carcinoma of Large Cell Histology
United States, Australia, Belgium, China, France +6 more
Sponsor: Italfarmaco
Duchenne Muscular Dystrophy
Belgium, Canada, Czechia, France, Germany +7 more
Sponsor: Boehringer Ingelheim
Non-small Cell Lung Cancer
United States, Argentina, Australia, Austria, Belgium +23 more